Last updated: February 20, 2025
Sponsor: Christiana Care Health Services
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism Spectrum Disorder (Asd)
Asperger's Disorder
Autism
Treatment
transcranial magnetic stimulation
Clinical Study ID
NCT06807684
DDD 605632
Ages 13-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria
Fulfilling the DSM-V criteria for ASD and confirmed by CARS2, HF Exclusion criteria
Patients with ASD exhibiting significant anxiety or contact avoidance, precluding them from cooperating with the procedure
Patients with a known diagnosis of seizures
Presence of any metallic implants or devices in the head or neck area
Pregnant women
Study Design
Total Participants: 12
Treatment Group(s): 1
Primary Treatment: transcranial magnetic stimulation
Phase:
Study Start date:
August 15, 2024
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Christiana Care
Newark, Delaware 19718
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.